News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fibrocell Science, Inc. to Present at Rodman & Renshaw 15th Annual Global Investment Conference


9/4/2013 7:48:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Fibrocell Science, Inc. (NYSE MKT:FCSC), an autologous cell therapy company primarily focused on developing innovative products for difficult-to-treat skin diseases and conditions where autologous fibroblasts with or without genetic modification can play a key role in addressing unmet medical needs, today announced that David Pernock, Chairman and Chief Executive Officer, Fibrocell Science, will present at the Rodman & Renshaw 15th Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is September 8-10, 2013, at the Millennium Broadway Hotel in New York City.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES